Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: Final event-driven analysis of the randomised, double-blind PATRICIA trial

Dan Apter; Henry C Kitchener; Julio C Teixeira; Unnop Jaisamrarn; Gerara Limson; Anne Szarewski; Barbara Romanowski; FY Aoki; Tino F Schwarz; Willy A Poppe; Xavier F Bosch; Cosette M Wheeler; Adrian Mindel; Philippe de Sutter; Karin Hardt; Toufik Zahaf; Dominique Descamps; Frank Struyf; Matti Lehtinen; Gary Dublin; Jorma Paavonen; Xavier Castellsagué; Suzanne M Garland; Rachel S Skinner; Paulo Naud; Jorge Salmerón; Song-Nan Chow

doi:10.1128/CVI.00591-14

Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: Final event-driven analysis of the randomised, double-blind PATRICIA trial

Dan Apter, Henry C Kitchener, Julio C Teixeira, Unnop Jaisamrarn, Gerara Limson, Anne Szarewski, Barbara Romanowski, FY Aoki, Tino F Schwarz, Willy A Poppe, Xavier F Bosch, Cosette M Wheeler, Adrian Mindel, Philippe de Sutter, Karin Hardt, Toufik Zahaf, Dominique Descamps, Frank Struyf, Matti Lehtinen, Gary DublinJorma Paavonen, Xavier Castellsagué, Suzanne M Garland, Rachel S Skinner, Paulo Naud, Jorge Salmerón, Song-Nan Chow

Tutkimustuotos: Artikkeli › Scientific › vertaisarvioitu

80 Sitaatiot (Scopus)

Alkuperäiskieli	Englanti
Sivut	361-373
Julkaisu	CLINICAL AND VACCINE IMMUNOLOGY
Vuosikerta	22
Numero	4
DOI - pysyväislinkit	https://doi.org/10.1128/CVI.00591-14
Tila	Julkaistu - 2015
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Julkaisufoorumi-taso

Jufo-taso 1

YK:n kestävän kehityksen tavoitteet

Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:

Pääsy asiakirjaan

10.1128/CVI.00591-14

Siteeraa tätä

Apter, D., Kitchener, H. C., Teixeira, J. C., Jaisamrarn, U., Limson, G., Szarewski, A., Romanowski, B., Aoki, FY., Schwarz, T. F., Poppe, W. A., Bosch, X. F., Wheeler, C. M., Mindel, A., de Sutter, P., Hardt, K., Zahaf, T., Descamps, D., Struyf, F., Lehtinen, M., ... Chow, S.-N. (2015). Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: Final event-driven analysis of the randomised, double-blind PATRICIA trial. CLINICAL AND VACCINE IMMUNOLOGY, 22(4), 361-373. https://doi.org/10.1128/CVI.00591-14

@article{c56e294b156e4c65be6a78a338b1fd9d,

title = "Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: Final event-driven analysis of the randomised, double-blind PATRICIA trial",

author = "Dan Apter and Kitchener, {Henry C} and Teixeira, {Julio C} and Unnop Jaisamrarn and Gerara Limson and Anne Szarewski and Barbara Romanowski and FY Aoki and Schwarz, {Tino F} and Poppe, {Willy A} and Bosch, {Xavier F} and Wheeler, {Cosette M} and Adrian Mindel and {de Sutter}, Philippe and Karin Hardt and Toufik Zahaf and Dominique Descamps and Frank Struyf and Matti Lehtinen and Gary Dublin and Jorma Paavonen and Xavier Castellsagu{\'e} and Garland, {Suzanne M} and Skinner, {Rachel S} and Paulo Naud and Jorge Salmer{\'o}n and Song-Nan Chow",

year = "2015",

doi = "10.1128/CVI.00591-14",

language = "English",

volume = "22",

pages = "361--373",

journal = "CLINICAL AND VACCINE IMMUNOLOGY",

issn = "1556-6811",

publisher = "American Society for Microbiology",

number = "4",

}

Apter, D, Kitchener, HC, Teixeira, JC, Jaisamrarn, U, Limson, G, Szarewski, A, Romanowski, B, Aoki, FY, Schwarz, TF, Poppe, WA, Bosch, XF, Wheeler, CM, Mindel, A, de Sutter, P, Hardt, K, Zahaf, T, Descamps, D, Struyf, F, Lehtinen, M, Dublin, G, Paavonen, J, Castellsagué, X, Garland, SM, Skinner, RS, Naud, P, Salmerón, J & Chow, S-N 2015, 'Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: Final event-driven analysis of the randomised, double-blind PATRICIA trial', CLINICAL AND VACCINE IMMUNOLOGY, Vuosikerta 22, Nro 4, Sivut 361-373. https://doi.org/10.1128/CVI.00591-14

Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: Final event-driven analysis of the randomised, double-blind PATRICIA trial. / Apter, Dan; Kitchener, Henry C; Teixeira, Julio C et al.
julkaisussa: CLINICAL AND VACCINE IMMUNOLOGY, Vuosikerta 22, Nro 4, 2015, s. 361-373.

Tutkimustuotos: Artikkeli › Scientific › vertaisarvioitu

TY - JOUR

T1 - Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: Final event-driven analysis of the randomised, double-blind PATRICIA trial

AU - Apter, Dan

AU - Kitchener, Henry C

AU - Teixeira, Julio C

AU - Jaisamrarn, Unnop

AU - Limson, Gerara

AU - Szarewski, Anne

AU - Romanowski, Barbara

AU - Aoki, FY

AU - Schwarz, Tino F

AU - Poppe, Willy A

AU - Bosch, Xavier F

AU - Wheeler, Cosette M

AU - Mindel, Adrian

AU - de Sutter, Philippe

AU - Hardt, Karin

AU - Zahaf, Toufik

AU - Descamps, Dominique

AU - Struyf, Frank

AU - Lehtinen, Matti

AU - Dublin, Gary

AU - Paavonen, Jorma

AU - Castellsagué, Xavier

AU - Garland, Suzanne M

AU - Skinner, Rachel S

AU - Naud, Paulo

AU - Salmerón, Jorge

AU - Chow, Song-Nan

PY - 2015

Y1 - 2015

U2 - 10.1128/CVI.00591-14

DO - 10.1128/CVI.00591-14

M3 - Article

SN - 1556-6811

VL - 22

SP - 361

EP - 373

JO - CLINICAL AND VACCINE IMMUNOLOGY

JF - CLINICAL AND VACCINE IMMUNOLOGY

IS - 4

ER -